TerminatedNot Applicable

Frequency Specific Microcurrent for the Treatment of Diastasis Recti

Stopped: Enrollment too slow.

United States13 participantsStarted 2020-01-01

Plain-language summary

Determine if frequency specific microcurrent therapy improves pain management of DRA by 30% or greater.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

\*\*Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study\*\* Inclusion Criteria: * Active Duty and DoD beneficiary Postpartum Females (12 hours to 24 hours) with Diastasis Rectus Abdominus (DRA) pain * Aged 18 years or older * Singleton gestation/delivered (one baby carried and born) * Vaginal delivery * Nulliparous (first pregnancy) or multiparous (more than one pregnancy in the past) Exclusion Criteria: * less than 18 years of age * females greater than 24 hours post-partum * Medical history to include pacemaker * History of arrhythmia * Transplant status * Insulin pump * Pain pump * Active cancer * Inability to measure IRD * Delivery via caesarean section * Operative vaginal delivery (vacuum or forceps) * 3rd or 4th degree vaginal laceration

What they're measuring

Inter-rectus Distances (IRD)

Timeframe: screening (pre and post initial treatment)

Inter-rectus Distances (IRD)

Timeframe: visit 2/week 2

Inter-rectus Distances (IRD)

Timeframe: visit 3/week 3

Trial details

NCT IDNCT04060563

SponsorDiana Trang

Sponsor typeFED

Study typeINTERVENTIONAL

Primary completion2021-07-07

Results submitted2024-01-12

View on ClinicalTrials.gov More Diastasis Recti trials